等待开盘 11-19 09:30:00 美东时间
-0.100
-1.08%
Vir Biotechnology, Inc. (NASDAQ:VIR) stock fell in Friday’s premarket trading after the clinical-stage biopharmaceutical company priced a $150 million public stock offering at $10 per share, raising concerns about shareholder dilution. $150 Million Equity Offering Vir Biotechnology priced 15 million...
11-13 21:39
今日重点评级关注:摩根士丹利:维持Riot Platforms"超配"评级,目标价从35.5美元升至41美元;Canaccord Genuity:维持塞德斯医疗"买入"评级,目标价从60美元升至68美元
11-10 18:30
三大指数齐涨逾2%,纳指创7月末来最大单日涨幅;AMD大涨13%,谷歌新TPU采用其处理器;AI数据中心基建股反弹,BE涨11%;英伟达跌超4%,市值缩水逾1900亿美元>>
11-10 06:59
Shares of Greenfire Resources Ltd (NYSE:GFR) rose sharply in pre-market trading after Strathcona Resources announced plans to acquire the company in a C$2.7 billion-C$2.9 billion deal, including C$550 million net debt. Greenfire Resources shares jumped 25.3% to $7.02 in pre-market trading Here are s...
11-09 17:25
今日重点评级关注:Citizens:维持Precigen"跑赢大市"评级,目标价从11美元升至12美元;Leerink Partners:维持Arcus Biosciences"跑赢大市"评级,目标价从46美元升至49美元
11-06 16:15
Needham analyst Joseph Stringer maintains Vir Biotechnology (NASDAQ:VIR) with a Buy and raises the price target from $18 to $20.
11-05 18:23
The latest update is out from Vir Biotechnology ( ($VIR) ). On October 26, 2026...
10-28 20:57
Spero Therapeutics appoints Amy Rock, Ph.D., as Chief Regulatory and Quality Officer and Dae Gon Ha, Ph.D., as Senior Vice President, Corporate Development. Rock brings over 25 years of experience in regulatory affairs and immunotherapy development, while Ha has expertise in biopharma markets and business development. Additionally, Chief Operating Officer Timothy Keutzer will retire after 11 years, during which he played a key role in advancing U...
10-26 12:00
Vir Biotechnology Announces Collaboration, License Agreement With Gilead To Discover, Engineer Three PRO-XTEN Dual-Masked T-Cell Engager Development Candidates Targeting Selected Solid Tumor-Associated Antigens
10-14 20:34